Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

OneSource Specialty Pharma Results Update

OneSource Specialty Pharma reported strong Q1FY27 results, with revenue growing 37% YoY and EBITDA increasing 39% YoY, driven by semaglutide commercialization and new customer wins.

Source

BSE filing, NSE: ONESOURCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

OneSource Specialty Pharma Ltd: key numbers

Share price
₹1,577.60
Market cap
₹18,091 Cr
Revenue (annual)
₹1,422 Cr
Net profit (annual)
₹-73.80 Cr
P/E (TTM)
-11160.2×Sector 46.1×
Promoter holding
30.47%-0.01% QoQ
FII holding
19.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from OneSource Specialty Pharma Ltd

All →
10:07 IST BSE
Financial Results

OneSource Specialty Pharma Q2 FY27 Results: Net Profit ₹57.5 Cr, Up 447.6% YoY

OneSource Specialty Pharma Ltd reported revenue from operations of ₹516.2 Cr (+37.4% YoY) and net profit of ₹57.5 Cr (+447.6% YoY) for Q2 FY27.

Key figure
Net profit ₹57.5 Cr · +447.6% YoY

Other results update announcements

All →